UNSPSC 51283925: Sulfaperin or sulfaperine

This classification denotes a sulfonamide anti-infective agent with the molecular formula C11H12N4O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W5E840UV9P, chemically known as sulfanilamide, n(sup 1)-(5-methyl-2-pyrimidinyl)- but generally known as sulfaperin, which bears US NIH Compound Identifier 68933. European Medicines Agency schedules Sulfaperin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10720MIG. The term SULFAPERINE is an International Non-Proprietary Name.

UNSPSC 51283925 Sulfaperin or sulfaperine, a Commodity code, shows minimal relevant recent state and local procurement activity. The two opportunities tagged under this code—a completed Illinois Department of Public Health pharmaceutical piggyback contract for Doxycycline Hyclate and Ciprofloxacin Hydrochloride, and a Seminole County, Florida procurement for Naloxone and drug deactivation systems—involve pharmaceutical products and medical supplies but do not align with the code's stated scope of sulfaperin or sulfaperine compounds. Neither opportunity explicitly references sulfaperin or sulfaperine procurement, suggesting either tagging misalignment or that state and local governments are not currently soliciting these specific pharmaceutical ingredients through open competitive processes.

The Illinois Department of Public Health issued an IFB (Invitation for Bid) process through the MMCAP Infuse cooperative purchasing consortium, awarding a $2,999,999.11 twelve-month contract with two renewal options to Chartwell Rx LLC on August 28, 2026, while Seminole County issued an IFB for quarterly deliveries with a deadline of July 26, 2023. The limited and mismatched activity suggests this code sees negligible purchasing volume or vendor interest at the state and local level at present.